

Featured in
Boston
Gene Editing for Cardiovascular Disease: Sek Kathiresan, Verve Tx
Registration
Past Event
About Event
Sek Kathiresan is the Founder & CEO of Verve Therapeutics, a company developing one-time genetic medicine treatments for cardiovascular disease.